Page last updated: 2024-10-26

etidronate and Neuromuscular Diseases

etidronate has been researched along with Neuromuscular Diseases in 1 studies

Etidronic Acid: A diphosphonate which affects calcium metabolism. It inhibits ectopic calcification and slows down bone resorption and bone turnover.
etidronic acid : A 1,1-bis(phosphonic acid) that is (ethane-1,1-diyl)bis(phosphonic acid) having a hydroxy substituent at the 1-position. It inhibits the formation, growth, and dissolution of hydroxyapatite crystals by chemisorption to calcium phosphate surfaces.

Neuromuscular Diseases: A general term encompassing lower MOTOR NEURON DISEASE; PERIPHERAL NERVOUS SYSTEM DISEASES; and certain MUSCULAR DISEASES. Manifestations include MUSCLE WEAKNESS; FASCICULATION; muscle ATROPHY; SPASM; MYOKYMIA; MUSCLE HYPERTONIA, myalgias, and MUSCLE HYPOTONIA.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Hozuki, T1
Imai, T1
Tsuda, E1
Matsumura, A1
Yamamoto, D1
Toyoshima, T1
Suzuki, S1
Yamauchi, R1
Hayashi, T1
Hisahara, S1
Shimohama, S1

Trials

1 trial available for etidronate and Neuromuscular Diseases

ArticleYear
Response of serum carboxylated and undercarboxylated osteocalcin to risedronate monotherapy and combined therapy with vitamin K(2) in corticosteroid-treated patients: a pilot study.
    Internal medicine (Tokyo, Japan), 2010, Volume: 49, Issue:5

    Topics: Adrenal Cortex Hormones; Adult; Aged; Biomarkers; Bone and Bones; Bone Density; Bone Density Conserv

2010